e-learning
resources
Virtual 2021
06.09.2021
Wheezing illnesses along the life span
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Biologics: current use and future applications for personalised therapy
E. Weersink (Amsterdam, Netherlands)
Source:
Virtual Congress 2021 – Wheezing illnesses along the life span
Session:
Wheezing illnesses along the life span
Session type:
Symposium
Number:
1636
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Weersink (Amsterdam, Netherlands). Biologics: current use and future applications for personalised therapy. Virtual Congress 2021 – Wheezing illnesses along the life span
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Anti-IgE therapy: current knowledge and future perspective
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019
Clinical use of new and repurposed drugs: the role and contribution of the ERS collaborative projects
Source: International Congress 2017 – In the frontline of the fight against tuberculosis
Year: 2017
Therapeutic management - Current status and future developments
Source: COVID-19 Videos
Year: 2020
New and future developments of therapy for asthma in children
Source: Eur Respir Mon 2012; 56: 224-234
Year: 2012
Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008
At the interface: the translational science supporting the clinical use of anti-cytokine therapy
Source: International Congress 2018 – New biologics for asthma: which patients, which agents, which results, at what cost?
Year: 2018
Challenges and limitations of individualised therapy
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Current and future preventive and treatment strategies in CLAD
Source: International Congress 2015 – When chronic inflammation drives fibrosis: a lesson from lung transplantation
Year: 2015
Other options of prevention - the current state and the future
Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches
Year: 2003
Getting approval for new therapeutic medical devices versus drugs: are the differences justified?
Source: Eur Respir Rev 2016; 25: 223-226
Year: 2016
From the bedside: upcoming new clinical strategies
Source: International Congress 2016 – Scientific Year in Review 2016
Year: 2016
In the era of personalized medicine, what are the current unmet needs in asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019
CF clinical care and its delivery: current and future challenges
Source: International Congress 2019 – Future of cystic fibrosis care: insights from the Lancet Commission
Year: 2019
Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation
Source: Eur Respir J 2014; 44: 1412-1417
Year: 2014
Clinical trial landscape for M/XDR-TB: current evidence and future perspectives
Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis
Year: 2019
Advances in targeted therapy: the clinicians point of view
Source: International Congress 2014 – Update on lung cancer biology for clinicians
Year: 2014
Rational monitoring of COPD: where do current clinical guidelines stand?
Source: Eur Respir J 2007; 29: 1078-1081
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept